Yahoo Finance

Auron Selects First Development Candidate for its Portfolio of Next-Generation Targeted Cancer Treatments from its Novel AURIGIN™ Platform

NEWTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and treating disrupted cell states ...
Yahoo Finance

Auron Therapeutics Announces FDA Clearance to Initiate Clinical Development of AUTX-703 and Completion of Series B Financing

NEWTON, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
FierceBiotech

With hopes of paving new path for cancer treatment, Eli Lilly-backed Auron raises $48M

Auron Therapeutics has exited stealth mode with $48 million and backing from Big Pharma Eli Lilly, touting a new machine-learning platform and lofty hopes to flip the current cancer treatment paradigm ...
IGN

Character Analysis (Auron)

***** ***** Final Fantasy X Character Analysis: Auron ***** ***** ===== = Table of Content ...
The Business Journals

Biotech raises Series B to test cancer drug in the clinic

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Auron Therapeutics has raised a $27 million Series B ...
C&EN

Auron Therapeutics completes $48 million series A to develop differentiation therapy for cancer

The Newton, Massachusetts–based company Auron Therapeutics has received $48 million in series A financing from investors including DCVC Bio and Eli Lilly and Company. Auron will expand its machine ...